Drug Type Autologous CAR-T |
Synonyms- |
Target |
Mechanism CD37 antagonists(Leukocyte antigen CD37 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
B-Cell Lymphoma | Phase 1 | US | 19 Jun 2020 | |
Leukemia | Phase 1 | US | 19 Jun 2020 | |
T-Cell Lymphoma | Phase 1 | US | 19 Jun 2020 |